Promisingly, anorectic gut hormones, including peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), have recently emerged as potential therapeutic targets for obesity. The gene discussed is PYY; the disease is obesity due to melanocortin 4 receptor deficiency.